Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

169

...

ATC	Name	B/G	Ingredients	Dosage	Form	Price
S01ED51	TRAVOPROST/TIMOLOL BIOGARAN	G	Travoprost - 40mcg/ml, Timolol - 5mg/ml		Drops solution	849,308 L.L
L01FD01	TRAZIMERA	BioTech	Trastuzumab - 440mg	440mg	Injectable powder for solution+solvent	75,295,202 L.L
L01FD01	TRAZIMERA	BioTech	Trastuzumab - 150mg	150mg	Injectable powder for solution	28,550,630 L.L
R05CB01	TREBON N	G	Acetylcysteine - 600mg	600mg	Granules for suspension	596,666 L.L
L04AC16	TREMFYA	BioTech	Guselkumab - 100mg/ml	100mg/ml	Injectable solution	190,195,151 L.L
L04AC16	TREMFYA	BioTech	Guselkumab - 100mg/ml	100mg/ml	Injectable solution	190,195,151 L.L
L04AC16	TREMFYA	BioTech	Guselkumab - 100mg/ml	100mg/ml	Injectable solution	L.L
N03AX18	TREPADIO	G	Lacosamide - 200mg/20ml	200mg/20ml	Injectable solution	9,569,390 L.L
A10AE06	TRESIBA	BioTech	Insulin degludec - 100IU/ml	100IU/ml	Injectable solution	6,857,628 L.L
D10AD01	TRETINOIN	G	Tretinoin - 0.05%	0.05%	Solution	623,287 L.L
D10AD01	TRETINOIN	G	Tretinoin - 0.025%	0.025%	Solution	564,414 L.L
D10AD01	TRETINOIN	G	Tretinoin - 0.1%	0.1%	Solution	682,160 L.L
N05AX13	TREVICTA	B	Paliperidone - 175mg	175mg	Injectable suspension, prolonged release	35,006,953 L.L
N05AX13	TREVICTA	B	Paliperidone - 263mg	263mg	Injectable suspension, prolonged release	40,713,332 L.L
N05AX13	TREVICTA	B	Paliperidone - 350mg	350mg	Injectable suspension, prolonged release	50,113,800 L.L
N05AX13	TREVICTA	B	Paliperidone - 525mg	525mg	Injectable suspension, prolonged release	75,169,378 L.L
H02AB08	TRIACORT	G	Triamcinolone acetonide - 40mg/ml	40mg/ml	Injectable suspension	745,833 L.L
J01DD04	TRIAXONE	G	Ceftriaxone (sodium) - 500mg	500mg	Injectable powder for solution+diluent	356,118 L.L
J01DD04	TRIAXONE	G	Ceftriaxone (sodium) - 1g	1g	Injectable powder for solution	438,093 L.L
J01DD04	TRIAXONE	G	Ceftriaxone (sodium) - 1g	1g	Injectable powder for solution	4,542,188 L.L
L04AA29	TRIJAN	G	Tofacitinib - 5mg	5mg	Tablet, film coated	54,863,315 L.L
L04AA29	TRIJAN	G	Tofacitinib - 10mg	10mg	Tablet, film coated	84,793,962 L.L
A11DB	TRILAGAVIT	G	Vitamin B12 - 1mg, Vitamin B6 - 100mg, Vitamin B1 - 200mg		Tablet, film coated	399,121 L.L
A11DB	TRILAGAVIT	G	Vitamin B12 - 1mg/3ml, Vitamin B6 - 100mg/3ml, Vitamin B1 - 100mg/3ml		Injectable solution	579,196 L.L
S01GA52	TRILLERG	G	Antazoline HCl - 0.5mg, Tetryzoline HCl - 0.4mg		Drops solution	310,428 L.L
C09AA05	TRILTEC	G	Ramipril - 1.25mg	1.25mg	Capsule	524,739 L.L
C09AA05	TRILTEC	G	Ramipril - 2.5mg	2.5mg	Capsule	255,970 L.L
C09AA05	TRILTEC	G	Ramipril - 5mg	5mg	Capsule	447,948 L.L
C09AA05	TRILTEC	G	Ramipril - 10mg	10mg	Capsule	575,933 L.L
C09BA05	TRILTEC PLUS	G	Ramipril - 10mg, Hydrochlorothiazide - 12.5mg		Tablet	2,243,577 L.L

...

169

...